23:49 , Aug 20, 2019 |  BC Extra  |  Company News

Management tracks: uniQure, Provention, Anaptys, FDA and more

uniQure N.V. (NASDAQ:QURE) promoted CSO Sander van Deventer to EVP, research and product development and Alex Kuta to EVP, operations from SVP, regulatory affairs. As a result, the gene therapy company said COO Scott McMillan...
23:54 , Aug 7, 2019 |  BC Extra  |  Company News

Management tracks: Gilead's McHutchison joins Assembly as CEO; plus Lilly, Vor, HiberCell, insitro and more

Assembly Biosciences Inc. (NASDAQ:ASMB) gained $2.39 (20%) to $14.25 Wednesday after hiring John McHutchison as president and CEO, succeeding Derek Small. Gilead Sciences Inc. (NASDAQ:GILD) announced last month that McHutchison would step down as CSO...
23:42 , Aug 2, 2019 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 14 profitable biotechs and pharmas are slated to report earnings this week. (A) Premarket in New York; during market hours in Tel Aviv Company Date Pre/post mkt 2Q19 EPS est...
00:19 , Jul 30, 2019 |  BC Extra  |  Company News

July 29 Company Quick Takes: Dupixent sales boost Sanofi; plus Twist, J&J, Alkermes and more

Despite multibillion dollar impairment, Sanofi beats on 2Q19 earnings  Sanofi (Euronext:SAN; NASDAQ:SNY) reported 2Q19 sales of €496 million from dermatitis and asthma drug Dupixent dupilumab, beating the Street's estimate of €411 million. The pharma also...
19:48 , May 3, 2019 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 22 profitable biotechs and pharmas are slated to report earnings this week. (A) During trading hours in Europe; premarket on U.S. exchange; (B) Fiscal 4Q; Company Date Pre/post mkt 1Q19...
22:38 , Mar 19, 2019 |  BC Extra  |  Company News

Management tracks: Medicines Co., Mallinckrodt, ArQule

The Medicines Co. (NASDAQ:MDCO) terminated the employment of Christopher Cox, EVP and chief corporate development officer, effective March 15. Details were not disclosed. Mallinckrodt plc (NYSE:MNK) hired Bryan Reasons as CFO. He will succeed interim...
20:49 , Feb 22, 2019 |  BioCentury  |  Finance

Earnings on deck

Earnings on deck At least 12 profitable biotechs and pharmas are slated to report earnings this week. (A) Six-month EPS Company Date Pre/post mkt 4Q18 EPS est 4Q17 EPS Expected chg Corcept Therapeutics Inc. (NASDAQ:CORT)...
00:50 , Jan 5, 2019 |  BC Extra  |  Company News

Flurry of management moves on eve of JPM

More than 30 biopharma companies announced executive changes to kick off the New Year, including Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) and Immunocore Ltd. (Abingdon, U.K.), both of which brought on former AstraZeneca plc (LSE:AZN; NYSE:AZN) executives...
23:24 , Nov 7, 2018 |  BC Extra  |  Company News

Management tracks: Myovant, Alkahest

Women’s health and endocrine disease company Myovant Sciences Ltd. (NYSE:MYOV) named Kim Sablich chief commercial officer and Jeff Nornhold SVP of pharmaceutical operations and development. Sablich was VP of primary care marketing in the U.S....
22:43 , Sep 13, 2018 |  BC Week In Review  |  Company News

Gottlieb rebukes Nostrum's 300% price hike for generic antibiotic

A price hike of more than 300% by Nostrum Pharmaceuticals LLC (New Brunswick, N.J.) for a 65-year-old antibiotic met swift condemnation by FDA Commissioner Scott Gottlieb on Sept. 11. Gottlieb said in a tweet that...